Abbott Laboratories 2012 Annual Report Download - page 31

Download and view the complete annual report

Please find page 31 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

29
Abbott 2012 Annual Report
Consolidated Balance Sheet
(dollars in thousands)
December 31 2012 2011 2010
Liabilities and Shareholders’ Investment
Current Liabilities:
Short-term borrowings $ 2,081,839 $ 2,347,859 $ 4,349,796
Trade accounts payable 1,796,990 1,721,127 1,535,759
Salaries, wages and commissions 1,427,765 1,260,121 1,328,665
Other accrued liabilities 6,787,995 7,854,994 6,014,772
Dividends payable 221,340 754,284 680,749
Income taxes payable 655,424 514,947 1,307,723
Current portion of long-term debt 308,823 1,026,896 2,044,970
Total Current Liabilities 13,280,176 15,480,228 17,262,434
Long-term Debt 18,085,302 12,039,822 12,523,517
Post-employment Obligations and Other Long-term Liabilities 9,056,234 8,230,698 8,022,770
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value
Authorized — 1,000,000 shares, none issued — — —
Common shares, without par value
Authorized — 2,400,000,000 shares
Issued at stated capital amount —
Shares: 2012: 1,675,930,484;
2011: 1,638,870,201; 2010: 1,619,689,876 11,754,552 9,817,134 8,744,703
Common shares held in treasury, at cost —
Shares: 2012: 99,262,992;
2011: 68,491,382; 2010: 72,705,928 (5,590,909) (3,687,478) (3,916,823)
Earnings employed in the business 24,150,996 20,907,362 19,215,768
Accumulated other comprehensive income (loss) (3,593,678) (2,597,185) (1,366,846)
Total Abbott Shareholders’ Investment 26,720,961 24,439,833 22,676,802
Noncontrolling Interests in Subsidiaries 92,271 86,312 88,329
Total Shareholders’ Investment 26,813,232 24,526,145 22,765,131
$67,234,944 $60,276,893 $60,573,852
The accompanying notes to consolidated financial statements are an integral part of this statement.